CALL_US +86-27-59207850
Intermediate Pharmaceutical Products
Intermediate Pharma
Pharmaceutical Formulation Intermediates

2',3',5'-Tri-O-acetyluridine CAS 4105-38-8

2',3',5'-Tri-O-acetyluridine is an orally available pro-drug of uridine approved by the FDA for the treatment of the rare autosomal recessive disorder called hereditary orotic aciduria. The drug was also approved for treating overdose of two chemotherapies (fluorouracil and capecitabine).

Specifications of 2',3',5'-Tri-O-acetyluridine CAS 4105-38-8

AppearanceWhite or almost white crystalline powderComplies
Loss on drying≤1.0%0.8%
Residue on ignition≤0.2%0.15%
Heavy metals≤20ppmComplies
Assay (HPLC)≥98.0%99.1%

Parameters of 2',3',5'-Tri-O-acetyluridine CAS 4105-38-8

Product parameters
Cas number:4105-38-8
Appearance:White or almost white crystalline powder
Package details:25kg/drum

Package of 2',3',5'-Tri-O-acetyluridine CAS 4105-38-8

Package of 2',3',5'-Tri-O-acetyluridine CAS 4105-38-8

Fortunachem Chemicals
Get In Touch With Fortunachem

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help

Related Pharmaceutical Intermediate Fine Chemicals
Latest News & Blogs

Keeping you up-to-date with all the latest information, news, and events about Fortunachem!